Because of the increased number of patients, growing reliance on multiple medications and the shift toward more expensive new medicines, the annual cost of
diabetes drugs nearly doubled in only six years, rising from $ 6.7 billion in 2001 to $ 12.5 billion in 2007 according to a study in the Oct. 27, 2008, issue of the Archives of Internal Medicine.
Not exact matches
Other early seeds include the hot
diabetes -
drug company Intarcia Therapeutics (which I wrote about in November) and the Jonathan Bush - helmed athenahealth (now worth
nearly $ 5 billion), which has become a prominent force in the age of the cloud - based doctor's office and hospital.
LONDON, Feb 6 - After
nearly a century building a company worth $ 125 billion based on injectable
drugs, Denmark's Novo Nordisk - the world's biggest insulin maker - wants to prove this year it can transform the
diabetes market with a pill.
Yet, it would take
nearly 40 years for the
drug to be approved in the United States as a treatment for type 2
diabetes.
In a database study of
nearly 26,000 beneficiaries of Tricare, the military health system, those taking statin
drugs to control their cholesterol were 87 percent more likely to develop
diabetes.
For example, an analysis of
nearly 24,000 patients with type 2
diabetes found that three
diabetes drugs — glipizide, glyburide, and glimepiride — caused a more than 50 percent greater risk of death compared to another
diabetes drug, Metformin.v The three
drugs are known as sulfonylureas, which work by spurring your body to produce more insulin.
Type 2
diabetes, which involves loss of insulin and leptin sensitivity, is easily preventable, and
nearly 100 percent reversible without
drugs.
Diabetes and glucose drugs: One of the reasons that pharmaceutical methods of treating diabetes have been so unsuccessful is because of their limited approach — nearly all diabetes drugs target one (or at most, a few) of the primary symptoms of diabetes, without actually addressing underlying
Diabetes and glucose
drugs: One of the reasons that pharmaceutical methods of treating
diabetes have been so unsuccessful is because of their limited approach — nearly all diabetes drugs target one (or at most, a few) of the primary symptoms of diabetes, without actually addressing underlying
diabetes have been so unsuccessful is because of their limited approach —
nearly all
diabetes drugs target one (or at most, a few) of the primary symptoms of diabetes, without actually addressing underlying
diabetes drugs target one (or at most, a few) of the primary symptoms of
diabetes, without actually addressing underlying
diabetes, without actually addressing underlying causes.
Still, as of August 2014, Reuters reports,
nearly 1,000 women had filed
drug injury lawsuits against Pfizer naming Lipitor as the cause of their
diabetes.
Studies show that women taking Lipitor and other statins have a
nearly 50 % chance of developing type 2
diabetes than women who did not take the
drug.
Giving the
drugs to
nearly 70,000 people with cardiovascular disease or
diabetes prevented an estimated 1,271 heart attacks and strokes in one year, Dr. James Dudl of Kaiser Permanente's Care Management Institute and his colleagues reported in the American Journal of Managed Care.